Jmac Enterprises LLC Gilead Sciences, Inc. Transaction History

Jmac Enterprises LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	BUY	$59.54 - $68.01 $59,540 - $68,010	1,000 Added 11.05%	10,050 $620,000
Q2 2022 Jul 25, 2022	BUY	$57.72 - $65.01 $11,544 - $13,002	200 Added 2.26%	9,050 $559,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $574,188 - $651,714	8,850 New	8,850 $565,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jmac Enterprises LLC, based on Form 13F filings with the SEC.

Stay updated on Jmac Enterprises LLC with notifications on news.